Axsome醫療 AXSM 深 滬
等待開盤 12-27 09:30:00 美东时间
152.05
-1.590
-1.03%
華盛通- 最 高154.22
- 今 開153.76
- 成交量 46.32万股
- 最 低 151.27
- 昨 收 153.64
- 總市值 76.65亿
- 52周最高 158.5646
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 79.19
- 委 比 60.63%
- 總股本 5041.26万
- 歷史最高 158.5646
- 量 比 0.89
- 振 幅 1.92%
- 歷史最低 1.94
- 每 手 1
- 風險率 16.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Axsome Therapeutics to Participate in Upcoming Investor Conferences
Axsome Therapeutics will participate in two investor conferences in December: the Piper Sandler 37th Annual Healthcare Conference on December 3 and the BofA Securities CNS Therapeutics Virtual Conference on December 8. Both events will include fireside chats and a live webcast for the Piper Sandler session, available on the company’s website. Axsome is a biopharmaceutical company focused on CNS disorders and has FDA-approved treatments for condit...
11-20 12:00
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Axsome Therapeutics acquires Baergic Bio from Avenue Therapeutics
Avenue Therapeutics (OTC:ATXI) agreed to sell its majority-owned subsidiary Baergic Bio to Axsome Therapeutics (AXSM). The deal includes global rights to BAER-101 (AZD7325), now renamed AXS-17, a GABA...
11-06 21:50
Axsome Therapeutics Signs Deal To Acquire Global Rights Of AZD7325 Novel Oral GABAA Receptor α2,3 From AstraZeneca
Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into an agreement to obtain exclusive
11-06 20:12
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
Needham Reiterates Buy on Axsome Therapeutics, Maintains $154 Price Target
Needham analyst Ami Fadia reiterates Axsome Therapeutics (NASDAQ:AXSM) with a Buy and maintains $154 price target.
11-04 17:23
Axsome Therapeutics shares are trading lower. The company reported Q3 financial results.
Axsome Therapeutics shares are trading lower. The company reported Q3 financial...
11-03 21:43
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
11-03 19:11
Uncovering Potential: Axsome Therapeutics's Earnings Preview
Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings ...
11-01 02:01
